XNYS · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
Edwards Lifesciences (EW) had 1 Form 144 pre-sale notice filed on 2026-05-15. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 5/12/2026 | Zovighian Bernard J | CEO | GIFT | -26,640 | — | — |
| 5/12/2026 | Zovighian Bernard J | CEO | GIFT | 26,640 | — | — |
| 5/12/2026 | Zovighian Bernard J | CEO | SELL | -845 | $78 | $66,250 |
| 5/12/2026 | Zovighian Bernard J | CEO | SELL | -35,506 | $78 | $2,766,762 |
| 5/11/2026 | Ullem Scott B. | CVP, Chief Financial Officer | OPTION_EXERCISE | 19,830 | — | — |
| 5/11/2026 | Ullem Scott B. | CVP, Chief Financial Officer | TAX_WITHHOLD | -11,004 | $80 | $879,880 |
| 5/11/2026 | Ullem Scott B. | CVP, Chief Financial Officer | OPTION_EXERCISE | -19,830 | — | — |
| 5/11/2026 | Markowitz Wayne | CVP, JAPAC | SELL | -593 | $80 | $47,280 |
| 5/11/2026 | Zovighian Bernard J | CEO | GIFT | -5,489 | — | — |
| 5/11/2026 | Zovighian Bernard J | CEO | GIFT | 5,489 | — | — |
| 5/11/2026 | Lippis Daniel J. | CVP, TAVR | TAX_WITHHOLD | -362 | $80 | $28,946 |
| 5/11/2026 | Zovighian Bernard J | CEO | OPTION_EXERCISE | 47,207 | — | — |
| 5/11/2026 | Zovighian Bernard J | CEO | TAX_WITHHOLD | -26,198 | $80 | $2,094,792 |
| 5/11/2026 | Zovighian Bernard J | CEO | OPTION_EXERCISE | -47,207 | — | — |
| 5/11/2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | OPTION_EXERCISE | 13,457 | — | — |
| 5/11/2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | TAX_WITHHOLD | -7,469 | $80 | $597,221 |
| 5/11/2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | OPTION_EXERCISE | -13,457 | — | — |
| 5/11/2026 | Chopra Daveen | CVP, TMTT & Surgical | OPTION_EXERCISE | 13,583 | — | — |
| 5/11/2026 | Chopra Daveen | CVP, TMTT & Surgical | TAX_WITHHOLD | -7,538 | $80 | $602,738 |
| 5/11/2026 | Chopra Daveen | CVP, TMTT & Surgical | OPTION_EXERCISE | -13,583 | — | — |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| Vanguard Group | 70,079,435 | $5,974,271,834 | — | 1/29/2026 |
| BlackRock | 50,975,492 | $4,708,606,210 | — | 8/13/2024 |
| JP Morgan Chase | 26,349,452 | $2,246,290,811 | — | 2/11/2026 |
| State Street | 25,991,524 | $2,215,777,421 | — | 2/13/2026 |
| Fidelity (FMR) | 16,582,547 | $1,413,662,134 | — | 2/17/2026 |
| Millennium Management | 6,502,638 | $554,349,889 | — | 2/17/2026 |
| Citadel Advisors | 2,550,027 | $217,389,802 | — | 2/17/2026 |
| AQR Capital | 2,241,751 | $191,109,205 | — | 2/17/2026 |
| Point72 | 478,767 | $40,814,887 | — | 2/17/2026 |
| Two Sigma | 391,386 | $33,365,657 | — | 2/17/2026 |
| DE Shaw | 89,515 | $7,631,154 | — | 2/17/2026 |
| Bridgewater Associates | 76,762 | $6,543,960 | — | 2/13/2026 |